लोड हो रहा है...
Idarucizumab for a traumatic head injury patient taking dabigatran
BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...
में बचाया:
| में प्रकाशित: | Int J Emerg Med |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer Berlin Heidelberg
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6326148/ https://ncbi.nlm.nih.gov/pubmed/31179930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12245-018-0202-y |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|